Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Skull and Cross Bones? Not likely.
They filed their last quarterly only 9 days after the quarter closed. They did not wait the typical 45 days.
They also filed paperwork changing their shell status.
"the Company has more than nominal operations as demonstrated by the services offered by its real estate lending company and has more than nominal assets that are used in the operation of its business. Therefore, the Company is not currently a “shell company” as defined in Rule 405 of the Securities Act of 1933 as well as SEC Release No. 33-8587 and footnote 172 of SEC Release No.33-8869."
A share structure that large also means it will never get out of .0001s.
The restricted shareholders must be cashing in their chips.
Does not look promising with this one anymore.
Isn't that the truth. I have seen many penny stocks announce LOIs that never materialized.
Great info. We need to have you as the Investor Relations contact...hehe
Vince's role may have been reduced but that should not excuse him from answering shareholder inquiries.
Great to see some movement from Belisarian. Some observations.....
For the other stock, they gifted themselves 4.5M shares to be majority stockholder. That was easy to do with that one. The O/S was very small.
I wonder what the plan will be with ZHUD. Can they retrieve or cancel shares from the previous owner (not asking you...just thinking aloud)? If not, they will need to increase the Outstanding Shares.
The good thing about both shells is there is no dilutive debt that remains to be paid.
Looks like the bed is being cleaned and made today.
Getting the first missing quarter financials together is the hard part. They have to try and put pieces of the last company puzzle together. After that Q...the remainder should be easy. They need to have a solid tie-in from the previous company activity to when it became dormant.
No updates.
Catching up with the missing past financials is their current challenge.
It was probably a gift to himself. He gifted himself $500k worth of stock last year around this same time.
$300k annual salary is not enough in this economy. <grin>
10Q is out.
$6k in direct sales.
$81k royalty/licensing. Says $67k is from a former related party....whatever that means. This 67k is tied to the 300k sale they mentioned at beginning of the year.
Concrete company acquisition still has not materialized. They need to raise $25M for the acquisition.
The filings paint the bad picture. Level 2 is the reality of the filings.
The last time ENDV actually filed an ER without filing for an extension was 2Q 2019.
Looks like we will see Q1 ER posting on Monday.
Is not possible to post photo via ihub app. Even from the webpage login is a difficult process to figure out for the first time.
An alternative is to post on Stocktwits.
Stocks to watch under $0.10
https://thestreetreports.com/stocks-under-10%c2%a2-to-watch-now-pnnx-enzc-dtii-blqc/
Not even our letter writing campaign initiated a response from the company.
We are the company mushrooms. <grin>
Highest trading volume since mid January. And it is positive buying volume.
BANI is now officially on Expert Market.
Quarterly was released.
Wonder why they released the annual again?
Nothing wrong with supporting that.
I do question the $10 million sales projection within the next 12 months though.
This stock has historically been sell..sell...sell...halt trading for months...reverse split....then return to trading....rinse and repeat.
Will things be different with this new company?
Does not look promising by looking at the trading activity.
Interesting looking level 2.
CFGN amd PUMA facing off each other on the Bid and Ask.
It did not happen
Averaging down on a stock with dilution and increasing float is a bad investment strategy.
AVVH is not diluting nor increasing the float.
Cooley has a recent bad reputation for selling shells to bad companies. Dump and run!
Cooley is sticking around AVVH as he sees the potential of big money once AVVH becomes fully operational.
Investors need to be aware of FALSE pumping campaigns!!!
It is stated in black and white in the latest filing.
"There were 29,934,322,257 shares of our common stock outstanding as of May 1, 2023."
10 Billion more is being added to the float on top of the current 30B
FACTS!!!
Thanks for the detail. I just glanced for the numbers. Never seen a filing like this come from a shareholder situation.
Just assumed it was the company.
Interesting.
Surprise. Another 10 Billion share offering.
"There were 29,934,322,257 shares of our common stock outstanding as of May 1, 2023."
Add 10Billion more to that with the offering.
This is not going up. LOL
All those previous buys at .07 now being sold for a loss?
We can look forward to Q1 ER within the next week to be our next "communication" from PNNX.
Thanks for the update.
Would be nice for PNNX to update all shareholders on current status and future outlook in general.
Correction.
Only Canada brokers allow trading while on Expert Market. U.S. brokers will only assist with selling to get off your account. You cannot buy with U.S. brokers.
$10 Million?
Endonovo Launches SofPulse® into the Veterans Administration
Los Angeles, CA, May 02, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) a US-based biotechnology developer, today announced the launch of SofPulse® with Academy Medical, Inc., a Service-Disabled Veteran-Owned Small Business (SDVOSB) Government Reseller.
As was previously announced, Academy Medical will be reselling SofPulse® medical devices to the Veterans Health Administration (VHA) healthcare facilities, thereby ensuring its availability to the country’s military, veterans and their families. This sales launch meeting marks the beginning of the partnership between Endonovo and Academy Medical.
The partnership is expected to benefit military personnel, veterans and their families who are among the largest user groups of these healthcare delivery systems.
SofPulse® Included in VHA Procurement System
With the launch of SofPulse® into the Federal marketplace Endonovo, along with Academy Medical, have the potential to significantly improve access to SofPulse® to military personnel and veterans. The addition of SofPulse® into the VHA procurement system offers Endonovo the ability to sell into the largest healthcare Integrated Delivery Network (IDN) in the country. The procurement system is designed to streamline logistics and supply management for medical and surgical items providing veterans and military healthcare facilities with easier access to the products they need.
In making the announcement, Ira Weisberg, President of Endonovo’s Medical Division said: "The launch of SofPulse® in partnership with Academy Medical is an important element in our Go-to-Market Strategy providing an important opportunity to greatly expand its distribution throughout veterans and military healthcare facilities. Together we plan to bring better medical solutions to our veterans and their families and provide improved access SofPulse®. We expect to sell $10 million in the next twelve into the federal supply system.”
Academy Medical is a reliable provider of medical and surgical items to the Federal marketplace with over 45,000 products from more than 30 supplier partners.
“The partnership between Academy Medical and Endonovo provides veterans an opportunity to benefit from the device’s unique PEMF technology,” according to CEO, Tory Crawford, Army veteran.
Improved Healthcare for Military Personnel and Veterans
The sales launch with Academy Medical reaffirms that both companies have joined forces to improve healthcare solutions for military personnel and veterans. The partnership aims to provide better access to medical and surgical supplies, along with telehealth solutions, with the goal of making a tangible impact on the lives of those who have served their country. The VHA, which serves 9 million enrolled veterans annually through its 1,298 healthcare facilities, including 171 medical centers and 1,113 outpatient sites, will benefit from the inclusion of SofPulse® medical devices in the VHA procurement system.
The proven postoperative pain and edema reduction solution will be readily available to military personnel and veterans. Together Endonovo and Academy Medical anticipates significant advancements in healthcare for those who have bravely served their country.
SofPulse® Postoperative Pain and Edema Relief
Endonovo's SofPulse® PEMF devices provide a clinically proven and FDA-cleared alternative to opioid pain management, specifically for reducing postoperative pain and edema. With the launch of sales initiatives surrounding the partnership, Academy Medical aims to expand the distribution of SofPulse® devices, benefiting military personnel and veterans with improved recovery times and reduced opioid use. Endonovo's commercialization of the SofPulse® line is led by Weisberg, a seasoned expert in revenue growth for medical device companies, positioning the company for success.
Growth Opportunities
Endonovo's mission to revolutionize medical solutions for patients with a range of conditions includes advancing its patented technology for Central Nervous System (CNS) and Traumatic Brain Injury (TBI). The commencement of the VA partnership with Academy Medical is expected to create significant R&D and growth prospects for SofPulse®. In addition, recent FDA clearance inquiries could lead to further partnerships. With SofPulse® technology, the Company is well-positioned to develop new therapies and treatments for CNS-related diseases and conditions.
About Endonovo Therapeutics, Inc.
Endonovo Therapeutics is currently structured into two divisions: Legacy – a commercial-stage developer primarily of noninvasive wearable Electroceuticals® therapeutic devices for pain relief, general wellness and wound curatives with many of its products marketed under the SofPulse® brand name; and its Build Up Strategy – acquiring complementary specialty service providers in the construction industry.
About Academy Medical, Inc.
Academy Medical is a premier Service-Disabled Veteran-Owned Small Business and distributor of medical-surgical equipment and supplies to the U.S. Federal Government. As a government procurement partner with industry expertise and access to advanced technology, Academy Medical’s mission is to leverage its preferred status as an SDVOSB to create a streamlined, more cost-effective process for its government customers and supplier partners.
Academy Medical is headquartered in West Palm Beach, Florida. Learn more about partnering with the company in its service-driven business at www.academymedical.net.
Unfortunately... nothing that we can see or know of.
Who knows what is happening behind the scene.
What are you talking about?
Provide proof that the PEMF signal from Sofpulse does any of what you have mentioned.
The consultants must be cashing in their shares.
We have hit the longest stretch of consecutive days with 0 trading volume.
Certificate of Designation / Stock Change
Any way to see the details?
I click on the "view" but no document appears.
Ouch...SP certainly did not stick.
Seems they released today's fluff to try and cushion some dilution.
Get some cheapies for a flip.
Shareholders are being treated like mushrooms.
Kept in the dark, left uninformed and fed manure. The manure being uplisting news from 2 years ago...revenues of Millions (2 years ago), and 4.0 being released with fabulous upgrades and thousands of deals.